MeiraGTx Holdings (MGTX) Cash from Operations Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 158.60% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 300.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 300.16% |
| Sep 30, 2025 | 51.28% |
| Jun 30, 2025 | -126.01% |
| Mar 31, 2025 | -0.24% |
| Dec 31, 2024 | -60.01% |
| Sep 30, 2024 | -2.49% |
| Jun 30, 2024 | 32.94% |
| Mar 31, 2024 | 1.74% |
| Dec 31, 2023 | 10.57% |
| Sep 30, 2023 | -17.79% |
| Jun 30, 2023 | -4.33% |
| Mar 31, 2023 | -350.61% |
| Dec 31, 2022 | -186.40% |
| Sep 30, 2022 | -20.62% |
| Jun 30, 2022 | -30.79% |
| Mar 31, 2022 | -191.33% |
| Dec 31, 2021 | 163.69% |
| Sep 30, 2021 | -87.98% |
| Jun 30, 2021 | -65.07% |
| Mar 31, 2021 | 173.37% |
| Dec 31, 2020 | -34.55% |
| Sep 30, 2020 | 50.34% |
| Jun 30, 2020 | 40.77% |
| Mar 31, 2020 | -115.07% |
| Dec 31, 2019 | -91.58% |
| Sep 30, 2019 | -67.42% |
| Jun 30, 2019 | -14.27% |
| Mar 31, 2019 | 572.33% |
| Dec 31, 2018 | -209.18% |
| Sep 30, 2018 | -188.16% |